Cell Death and DiseaseNeurosciencePeer-reviewed journal article
Nucleolar stress controls mutant Huntingtin toxicity and monitors Huntington disease progression
Aynur Soenmez, Rasem MustafaiD, Salome T. Ryll, Francesca TuortoiD, Ludivine WacheuliD, Donatella PontiiD, Christian LitkeiD, Tanja Hering, Kerstin Kojer, Jenniver Koch, Claudia PitzeriD, Joachim KirschiD, Andreas NeuederiD, Grzegorz KreineriD, Denis L. J. LafontaineiD, Michael OrthiD, Birgit LissiD, Rosanna ParlatoiD
Abstract
Transcriptional and cellular stress surveillance deficits are hallmarks of Huntingtons disease (HD), a fatal autosomal dominant neurodegenerative disorder, caused by a pathological expansion of CAG repeats in the Huntingtin (HTT) gene. The nucleolus, a dynamic nuclear biomolecular condensate and the site of ribosomal RNA (rRNA) transcription, is implicated in the cellular stress response and in protein quality control. While the exact pathomechanisms of HD remain unclear, the impact of nucleolar dysfunction on HD pathophysiology in vivo is elusive. Here we identified aberrant maturation of rRNA and decreased translational rate in association with human mutant Huntingtin (mHTT) expression. Genetic disruption of nucleolar integrity in vulnerable striatal neurons of the R6/2 HD mouse model decreases mHTT disperse state in the nucleus, exacerbating the motor deficits. The protein nucleophosmin 1 (NPM1), important for nucleolar integrity and rRNA maturation, loses its nucleolar localization. NPM1 de-localization occurs in the striatum and in the skeletal muscle of the progressive zQ175 knock-in HD mouse model, mimicking the phenotype of HD patients in skeletal muscle biopsies. Taken together, we showed that nucleolar integrity regulates the formation of mHTT inclusions in vivo, and identified NPM1 as a novel, readily detectable peripheral histopathological marker of HD progression.
- organism: mouse
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: protein structure prediction
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 29
- FWCI
- 1.84
- Field percentile
- top 15%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcriptomic Characterization Reveals Disrupted Medium Spiny Neuron Trajectories in Huntington's Disease and Possible Therapeutic Avenues
Carlos Galicia Aguirre, Kizito‐Tshitoko Tshilenge, … Lisa Ellerby·bioRxiv·Apr 30, 2023
- Developmental and physiological impacts of pathogenic human huntingtin protein in the nervous system
Tadros A. Hana, Veronika G. Mousa, … Kiel G. Ormerod·Neurobiology of DiseasePeer-reviewed·Nov 12, 2024
- Single-nucleus RNA-seq reveals dysregulation of striatal cell identity due to Huntington’s disease mutations
Sonia Malaiya, Marcia Cortes-Gutierrez, … Seth A. Ament·Journal of NeurosciencePeer-reviewed·May 19, 2021
- The human-specific lncRNA HD-LINC drives lipid droplet-associated neurodegeneration in Huntington's disease
Ji‐Sun Kwon, Liyuan Wang, … Andrew S.J. Yoo·bioRxiv·Oct 27, 2026
- Neuron-specific increase in lamin B1 disrupts nuclear function in Huntington's disease
Rafael Alcalá‐Vida, Marta García-Forn, … Esther Pérez‐Navarro·bioRxiv·Mar 6, 2020
- A role of cellular translation regulation associated with toxic Huntingtin protein
H. Joag, V. Ghatpande, … A. Majumdar·bioRxiv·Jul 1, 2019